Meningococcal infection is a deadly bacterial infection induced by causative agent Neisseria meningitis which triggers the inflammation of the membrane which covers the brain and spinal cord. The rate of invasive infection has rapidly increased in 2017, displaying the highest rate of the infection amongst the territory such as New South Wales, northern territory, Queensland, South Australia, Tasmania, Victoria, and Western Australia. The diagnosis includes samples of blood and cerebrospinal fluid. The risk factors and symptoms include infectious individuals, throat discharge of individual carrying bacteria, smoking, kissing, persistent headache, joint pain and fever, discomfort, and nausea. The facilities available for the vaccinations include Bexsero, a series of 2 shots would be given to the patients with infection. While other vaccines of meningococcal such as A, C, W, and Y are available, Bexsero are required to purchase for 2 to 3 shots. Free screening along with health literacy session would be provided to the audience regarding the risk factor of the disease, how vaccination help to reduce it.
![[object Object]](/_next/image/?url=%2F_next%2Fstatic%2Fmedia%2Flogo.6d15ce61.png&w=640&q=75){kind=small}
![[object Object]](/_next/static/media/star-bottom.7253800d.svg)
